CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 14 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05170295
NCT05170295N/ACompleted

Noninvasive Monitoring of Cerebral Blood Flow Autoregulation

Ochsner Health System·observational·Posted Dec 27, 2021·Updated Dec 27, 2021

In Brief

An observational study for Intracranial Pressure Increase and Cerebral Edema. Completed, enrolled 14 participants across 1 site.

Detailed Summary

Rheoencephalography (REG) shows promise as a method for noninvasive neuromonitoring, because it reflects cerebrovascular reactivity. This protocol will study clinical and technical conditions required to use REG. Additionally, our goal is to study noninvasive peripheral bioimpedance pulse waveforms in order to substitute invasive SAP. A previous study demonstrated that REG can be used to detect spreading depolarization (SD), the early sign of brain metabolic disturbance. SD can be measured invasively with DC EEG amplifiers only. Our goal is to create an automatic notification function for REG monitoring indicating change of clinical conditions.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedDec 27, 2021
Enrollment StartApr 18, 2018
Primary CompletionApr 28, 2021
TodayJul 2, 2026
Enrollment to primary: 3.0 yearsPosted 4.5 years ago